
FibroGen
Discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs.
Market cap
$21.1m
Enterprise value
$61m
Share price
$5.30 FGEN
Authorizing premium user...
Discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs.